Vertex Pharmaceuticals - 33 Year Stock Price History | VRTX

Historical daily share price chart and data for Vertex Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Vertex Pharmaceuticals as of November 07, 2024 is 502.45.
  • The all-time high Vertex Pharmaceuticals stock closing price was 505.78 on August 01, 2024.
  • The Vertex Pharmaceuticals 52-week high stock price is 510.63, which is 1.6% above the current share price.
  • The Vertex Pharmaceuticals 52-week low stock price is 341.90, which is 32% below the current share price.
  • The average Vertex Pharmaceuticals stock price for the last 52 weeks is 439.78.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vertex Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 449.9909 410.9100 505.7800 392.8100 502.4500 23.49%
2023 339.1680 286.0200 410.6800 283.2300 406.8900 40.90%
2022 274.5959 222.5300 321.4800 221.4200 288.7800 31.50%
2021 204.4323 229.4300 241.3100 177.0100 219.6000 -7.08%
2020 251.5545 219.4500 303.1000 199.7700 236.3400 7.94%
2019 184.7418 164.0800 223.9100 163.7300 218.9500 32.13%
2018 167.4049 152.9100 192.7400 145.7200 165.7100 10.58%
2017 126.9038 74.8900 166.1100 74.8900 149.8600 103.42%
2016 88.1828 122.8900 123.4500 72.0200 73.6700 -41.45%
2015 123.7852 123.0700 141.4800 98.5000 125.8300 5.92%
2014 89.4849 73.8300 120.7800 62.4400 118.8000 59.89%
2013 68.0295 43.6500 88.5100 43.6500 74.3000 77.33%
2012 47.3818 32.2300 64.8500 32.2000 41.9000 26.17%
2011 44.0248 35.9900 58.0100 26.6000 33.2100 -5.20%
2010 36.8595 44.2400 44.2400 32.1500 35.0300 -18.25%
2009 33.6777 30.6900 43.5500 26.2300 42.8500 41.05%
2008 25.9329 23.1500 34.6800 14.5900 30.3800 30.78%
2007 31.3792 36.9000 40.5600 23.2300 23.2300 -37.92%
2006 35.8992 27.9000 45.1200 27.9000 37.4200 35.24%
2005 16.3817 10.2400 28.9200 8.8300 27.6700 161.78%
2004 10.0132 10.5000 11.9100 8.1700 10.5700 2.13%
2003 12.7675 16.3600 16.4000 8.0000 10.3500 -34.70%
2002 20.1402 24.5400 31.6100 12.9500 15.8500 -35.54%
2001 38.1837 63.1300 74.1900 16.5200 24.5900 -65.61%
2000 51.5357 18.7500 97.2500 16.7500 71.5000 308.57%
1999 13.1561 14.7200 17.5450 9.9400 17.5000 17.65%
1998 13.7489 16.6900 19.6250 7.6250 14.8750 -9.85%
1997 18.9003 19.1250 25.5650 12.8750 16.5000 -18.01%
1996 14.7045 13.0000 20.1250 11.0000 20.1250 51.89%
1995 8.4467 7.5000 13.2500 6.3750 13.2500 76.67%
1994 7.1147 9.0600 9.6250 5.2500 7.5000 -18.92%
1993 5.5591 5.1250 9.3750 3.3750 9.2500 89.74%
1992 5.3817 7.5000 8.6250 3.3750 4.8750 -33.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $129.396B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $173.037B 16.75
Gilead Sciences (GILD) United States $121.885B 22.10
Bristol Myers Squibb (BMY) United States $110.962B 46.76
CSL (CSLLY) Australia $91.941B 0.00
Regeneron Pharmaceuticals (REGN) United States $90.602B 20.62
GSK (GSK) United Kingdom $75.979B 8.79
Argenex SE (ARGX) Netherlands $35.366B 0.00
Alnylam Pharmaceuticals (ALNY) United States $35.111B 0.00
BioNTech SE (BNTX) Germany $25.650B 0.00
Biogen (BIIB) United States $25.344B 10.88
Illumina (ILMN) United States $24.607B 89.68
BeiGene (BGNE) Cayman Islands $20.133B 0.00
Moderna (MRNA) United States $19.327B 0.00
Incyte (INCY) United States $15.863B 0.00
Genmab (GMAB) Denmark $15.293B 22.44
Insmed (INSM) United States $12.826B 0.00
Vaxcyte (PCVX) United States $12.800B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.758B 29.62
Bio-Techne Corp (TECH) United States $12.143B 46.88
Sarepta Therapeutics (SRPT) United States $11.502B 103.81
Exelixis (EXEL) United States $10.224B 23.25
QIAGEN (QGEN) Netherlands $10.075B 20.73
Revolution Medicines (RVMD) United States $9.942B 0.00
Exact Sciences (EXAS) United States $9.852B 0.00
Intra-Cellular Therapies (ITCI) United States $9.596B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Roivant Sciences (ROIV) United Kingdom $8.697B 0.00
Repligen (RGEN) United States $8.058B 122.97
Ascendis Pharma (ASND) Denmark $7.674B 0.00
Viking Therapeutics (VKTX) United States $7.672B 0.00
Halozyme Therapeutics (HALO) United States $7.589B 17.14
Legend Biotech (LEGN) United States $7.465B 0.00
Cytokinetics (CYTK) United States $6.570B 0.00
Blueprint Medicines (BPMC) United States $6.441B 0.00
Nuvalent (NUVL) United States $6.097B 0.00
Krystal Biotech (KRYS) United States $5.334B 88.31
Arcellx (ACLX) United States $5.330B 0.00
Avidity Biosciences (RNA) United States $5.217B 0.00
Biohaven (BHVN) United States $5.019B 0.00
Alkermes (ALKS) Ireland $4.687B 15.74
Ultragenyx Pharmaceutical (RARE) United States $4.657B 0.00
ADMA Biologics Inc (ADMA) United States $4.596B 49.30
CRISPR Therapeutics AG (CRSP) Switzerland $4.428B 0.00
Immunovant (IMVT) United States $4.381B 0.00
Axsome Therapeutics (AXSM) United States $4.308B 0.00
Denali Therapeutics (DNLI) United States $4.260B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.927B 0.00
Merus (MRUS) Netherlands $3.731B 0.00
ImmunityBio (IBRX) United States $3.692B 0.00
Apellis Pharmaceuticals (APLS) United States $3.575B 0.00
Guardant Health (GH) United States $3.532B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.465B 0.00
Iovance Biotherapeutics (IOVA) United States $3.436B 0.00
Edgewise Therapeutics (EWTX) United States $3.322B 0.00
Amicus Therapeutics (FOLD) United States $3.281B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.259B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.237B 0.00
Kymera Therapeutics (KYMR) United States $3.229B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.102B 0.00
Zai Lab (ZLAB) China $3.069B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.853B 22.05
Janux Therapeutics (JANX) United States $2.845B 0.00
Protagonist Therapeutics (PTGX) United States $2.804B 17.90
Vera Therapeutics (VERA) United States $2.689B 0.00
Twist Bioscience (TWST) United States $2.667B 0.00
CG Oncology (CGON) United States $2.620B 0.00
Apogee Therapeutics (APGE) United States $2.612B 0.00
IDEAYA Biosciences (IDYA) United States $2.592B 0.00
Geron (GERN) United States $2.586B 0.00
Belite Bio (BLTE) United States $2.522B 0.00
Keros Therapeutics (KROS) United States $2.520B 0.00
SpringWorks Therapeutics (SWTX) United States $2.458B 0.00
Vericel (VCEL) United States $2.453B 833.83
Akero Therapeutics (AKRO) United States $2.421B 0.00
Ligand Pharmaceuticals (LGND) United States $2.373B 61.27
Longboard Pharmaceuticals (LBPH) United States $2.325B 0.00
Scholar Rock Holding (SRRK) United States $2.317B 0.00
Bavarian Nordic (BVNRY) Denmark $2.315B 12.39
Structure Therapeutics (GPCR) United States $2.193B 0.00
Beam Therapeutics (BEAM) United States $2.161B 0.00
Neumora Therapeutics (NMRA) United States $2.084B 0.00
MannKind (MNKD) United States $2.032B 52.79
NeoGenomics (NEO) United States $2.031B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.991B 16.55
Mirum Pharmaceuticals (MIRM) United States $1.960B 0.00
Nurix Therapeutics (NRIX) United States $1.930B 0.00
Spyre Therapeutics (SYRE) United States $1.919B 0.00
NovoCure (NVCR) Jersey $1.910B 0.00
Arvinas (ARVN) United States $1.907B 0.00
Disc Medicine (IRON) United States $1.883B 0.00
WAVE Life Sciences (WVE) Singapore $1.850B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.837B 0.00
Galapagos (GLPG) Belgium $1.810B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.780B 0.00
Certara (CERT) United States $1.769B 49.96
Celldex Therapeutics (CLDX) United States $1.756B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.716B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.661B 0.00
Intellia Therapeutics (NTLA) United States $1.625B 0.00
Fortrea Holdings (FTRE) United States $1.617B 50.14
Myriad Genetics (MYGN) United States $1.605B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.589B 0.00
Viridian Therapeutics (VRDN) United States $1.579B 0.00
Dynavax Technologies (DVAX) United States $1.575B 92.46
Rocket Pharmaceuticals (RCKT) United States $1.570B 0.00
Arcus Biosciences (RCUS) United States $1.506B 0.00
Novavax (NVAX) United States $1.470B 0.00
Gyre Therapeutics (GYRE) United States $1.407B 0.00
Praxis Precision Medicines (PRAX) United States $1.404B 0.00
Upstream Bio (UPB) United States $1.387B 0.00
Travere Therapeutics (TVTX) United States $1.378B 0.00
Kura Oncology (KURA) United States $1.362B 0.00
Vir Biotechnology (VIR) United States $1.346B 0.00
ANI Pharmaceuticals (ANIP) United States $1.228B 16.68
Bicara Therapeutics (BCAX) United States $1.222B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.217B 0.00
ArriVent BioPharma (AVBP) United States $1.197B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.173B 0.00
Zymeworks (ZYME) United States $1.155B 0.00
Applied Therapeutics (APLT) United States $1.119B 0.00
Immatics (IMTX) Germany $1.104B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.102B 0.00
Cogent Biosciences (COGT) United States $1.100B 0.00
MiMedx (MDXG) United States $1.093B 28.61
Septerna (SEPN) $1.092B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.075B 0.00
Mesoblast (MESO) Australia $0.987B 0.00
CARGO Therapeutics (CRGX) United States $0.986B 0.00
Rapport Therapeutics (RAPP) United States $0.984B 0.00
89BIO (ETNB) United States $0.980B 0.00
Cytek Biosciences (CTKB) United States $0.949B 0.00
Prothena (PRTA) Ireland $0.941B 0.00
Castle Biosciences (CSTL) United States $0.933B 166.55
Pliant Therapeutics (PLRX) United States $0.924B 0.00
Tyra Biosciences (TYRA) United States $0.906B 0.00
Cullinan Therapeutics (CGEM) United States $0.903B 0.00
Neurogene (NGNE) United States $0.903B 0.00
LENZ Therapeutics (LENZ) United States $0.895B 0.00
Erasca (ERAS) United States $0.879B 0.00
Dianthus Therapeutics (DNTH) United States $0.878B 0.00
IGM Biosciences (IGMS) United States $0.852B 0.00
Replimune (REPL) United States $0.834B 0.00
Zenas BioPharma (ZBIO) United States $0.832B 0.00
Liquidia Technologies (LQDA) United States $0.832B 0.00
Adaptive Biotechnologies (ADPT) United States $0.830B 0.00
Pacira BioSciences (PCRX) United States $0.817B 7.70
AbCellera Biologics (ABCL) Canada $0.803B 0.00
Avid Bioservices (CDMO) United States $0.781B 0.00
Annexon (ANNX) United States $0.778B 0.00
Immunome (IMNM) United States $0.753B 0.00
MBX Biosciences (MBX) United States $0.740B 0.00
Entrada Therapeutics (TRDA) United States $0.720B 12.09
Olema Pharmaceuticals (OLMA) United States $0.710B 0.00
Arbutus Biopharma (ABUS) United States $0.707B 0.00
BioAge Labs (BIOA) United States $0.705B 0.00
Mineralys Therapeutics (MLYS) United States $0.704B 0.00
Stoke Therapeutics (STOK) United States $0.703B 0.00
Oric Pharmaceuticals (ORIC) United States $0.702B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.693B 0.00
Sana Biotechnology (SANA) United States $0.690B 0.00
Oculis Holding AG (OCS) Switzerland $0.680B 0.00
Tectonic Therapeutic (TECX) United States $0.668B 0.00
Abivax SA (ABVX) France $0.667B 0.00
Allogene Therapeutics (ALLO) United States $0.667B 0.00
Astria Therapeutics (ATXS) United States $0.664B 0.00
AnaptysBio (ANAB) United States $0.654B 0.00
Nuvation Bio (NUVB) United States $0.653B 0.00
Anavex Life Sciences (AVXL) United States $0.647B 0.00
CorMedix Inc (CRMD) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
CureVac (CVAC) Germany $0.634B 0.00
Humacyte (HUMA) United States $0.628B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.620B 0.00
Revance Therapeutics (RVNC) United States $0.606B 0.00
ACELYRIN, INC (SLRN) United States $0.594B 0.00
Sangamo Therapeutics (SGMO) United States $0.585B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.585B 0.00
Celcuity (CELC) United States $0.582B 0.00
Emergent Biosolutions (EBS) United States $0.582B 0.00
Third Harmonic Bio (THRD) United States $0.572B 0.00
Q32 Bio (QTTB) United States $0.572B 0.00
Pharming Group (PHAR) Netherlands $0.564B 0.00
REGENXBIO (RGNX) United States $0.554B 0.00
Alumis (ALMS) United States $0.552B 0.00
Alector (ALEC) United States $0.552B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.550B 0.00
Aura Biosciences (AURA) United States $0.544B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.543B 0.00
ChromaDex (CDXC) United States $0.517B 677.00
Foghorn Therapeutics (FHTX) United States $0.506B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.505B 0.00
PureTech Health (PRTC) United States $0.498B 0.00
Terns Pharmaceuticals (TERN) United States $0.497B 0.00
Prime Medicine (PRME) United States $0.492B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.491B 0.00
Contineum Therapeutics (CTNM) United States $0.477B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.466B 0.00
GRAIL (GRAL) United States $0.463B 0.00
Absci (ABSI) United States $0.458B 0.00
GH Research (GHRS) Ireland $0.448B 0.00
Cartesian Therapeutics (RNAC) United States $0.444B 0.00
MeiraGTx Holdings (MGTX) United States $0.437B 0.00
C4 Therapeutics (CCCC) United States $0.426B 0.00
Voyager Therapeutics (VYGR) United States $0.387B 25.36
EnGene Holdings (ENGN) Canada $0.371B 0.00
Alpha Teknova (TKNO) United States $0.367B 0.00
MaxCyte (MXCT) United States $0.365B 0.00
UniQure (QURE) Netherlands $0.362B 0.00
XOMA Royalty (XOMA) United States $0.353B 0.00
Kamada (KMDA) Israel $0.344B 22.15
Jasper Therapeutics (JSPR) United States $0.343B 0.00
Sutro Biopharma (STRO) United States $0.341B 0.00
Codexis (CDXS) United States $0.340B 0.00
Artiva Biotherapeutics (ARTV) United States $0.339B 0.00
Northwest Biotherapeutics (NWBO) United States $0.339B 0.00
BioStem Technologies (BSEM) $0.338B 52.14
ITeos Therapeutics (ITOS) United States $0.335B 0.00
Nautilus Biotechnology (NAUT) United States $0.334B 0.00
Design Therapeutics (DSGN) United States $0.328B 0.00
AC Immune (ACIU) Switzerland $0.324B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.320B 0.00
Rezolute (RZLT) United States $0.320B 0.00
TScan Therapeutics (TCRX) United States $0.315B 0.00
Mersana Therapeutics (MRSN) United States $0.313B 0.00
Ocugen (OCGN) United States $0.311B 0.00
Tango Therapeutics (TNGX) United States $0.304B 0.00
Zura Bio (ZURA) United States $0.300B 0.00
Biomea Fusion (BMEA) United States $0.296B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.293B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.292B 0.00
Atea Pharmaceuticals (AVIR) United States $0.290B 0.00
Fate Therapeutics (FATE) United States $0.290B 0.00
GENFIT S.A (GNFT) France $0.285B 0.00
Poseida Therapeutics (PSTX) United States $0.285B 0.00
Urogen Pharma (URGN) United States $0.284B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Abeona Therapeutics (ABEO) United States $0.276B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.271B 0.00
Prima BioMed (IMMP) Australia $0.268B 0.00
Inozyme Pharma (INZY) United States $0.263B 0.00
Editas Medicine (EDIT) United States $0.262B 0.00
2seventy Bio (TSVT) United States $0.258B 0.00
Compass Therapeutics (CMPX) United States $0.253B 0.00
Kodiak Sciences (KOD) United States $0.253B 0.00
Anika Therapeutics (ANIK) United States $0.252B 0.00
Caribou Biosciences (CRBU) United States $0.252B 0.00
Precigen (PGEN) United States $0.240B 0.00
Amarin (AMRN) Ireland $0.236B 0.00
Climb Bio (CLYM) United States $0.236B 0.00
Opthea (OPT) Australia $0.236B 0.00
Inhibrx Biosciences (INBX) United States $0.235B 0.00
Lifecore Biomedical (LFCR) United States $0.235B 0.00
ATyr Pharma (ATYR) United States $0.235B 0.00
Nkarta (NKTX) United States $0.231B 0.00
Solid Biosciences (SLDB) United States $0.231B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.227B 0.00
Kyverna Therapeutics (KYTX) United States $0.227B 0.00
XBiotech (XBIT) United States $0.224B 0.00
Eton Pharmaceuticals (ETON) United States $0.224B 0.00
Cabaletta Bio (CABA) United States $0.224B 0.00
Trevi Therapeutics (TRVI) United States $0.223B 0.00
Molecular Partners AG (MOLN) Switzerland $0.221B 0.00
Fulcrum Therapeutics (FULC) United States $0.217B 0.00
ScPharmaceuticals (SCPH) United States $0.216B 0.00
Bright Minds Biosciences (DRUG) United States $0.215B 0.00
CAMP4 Therapeutics (CAMP) United States $0.205B 0.00
Gossamer Bio (GOSS) United States $0.201B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.199B 0.00
Tenaya Therapeutics (TNYA) United States $0.197B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.197B 0.00
Semper Paratus Acquisition (TVGN) United States $0.195B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.190B 0.00
Cardiff Oncology (CRDF) United States $0.190B 0.00
Sagimet Biosciences (SGMT) United States $0.190B 0.00
Scilex Holding (SCLX) United States $0.187B 0.00
Instil Bio (TIL) United States $0.185B 0.00
PepGen (PEPG) United States $0.183B 0.00
Greenwich LifeSciences (GLSI) United States $0.182B 0.00
Black Diamond Therapeutics (BDTX) United States $0.180B 0.00
DiaMedica Therapeutics (DMAC) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.171B 0.00
Skye Bioscience (SKYE) United States $0.165B 0.00
Adverum Biotechnologies (ADVM) United States $0.164B 0.00
Candel Therapeutics (CADL) United States $0.163B 0.00
Compugen (CGEN) Israel $0.162B 0.00
Nuvectis Pharma (NVCT) United States $0.161B 0.00
Akoya Biosciences (AKYA) United States $0.159B 0.00
Generation Bio (GBIO) United States $0.159B 0.00
Ventyx Biosciences (VTYX) United States $0.158B 0.00
Oncobiologics (OTLK) United States $0.158B 0.00
Checkpoint Therapeutics (CKPT) United States $0.156B 0.00
Innate Pharma S.A (IPHA) France $0.149B 0.00
Puma Biotechnology (PBYI) United States $0.149B 6.31
Repare Therapeutics (RPTX) Canada $0.148B 0.00
Verastem (VSTM) United States $0.145B 0.00
Inovio Pharmaceuticals (INO) United States $0.143B 0.00
Vigil Neuroscience (VIGL) United States $0.142B 0.00
Inventiva S.A (IVA) France $0.140B 0.00
INmune Bio (INMB) United States $0.138B 0.00
Seer (SEER) United States $0.136B 0.00
Adagene (ADAG) China $0.136B 0.00
Rani Therapeutics Holdings (RANI) United States $0.134B 0.00
Elutia (ELUT) United States $0.129B 0.00
FibroBiologics (FBLG) United States $0.126B 0.00
Seres Therapeutics (MCRB) United States $0.122B 0.00
PDS Biotechnology (PDSB) United States $0.121B 0.00
Coya Therapeutics (COYA) United States $0.121B 0.00
Allakos (ALLK) United States $0.121B 0.00
Adherex Technologies (FENC) United States $0.120B 0.00
Invivyd (IVVD) United States $0.119B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.116B 0.00
23andMe Holding (ME) United States $0.114B 0.00
Benitec Biopharma (BNTC) United States $0.114B 0.00
Annovis Bio (ANVS) United States $0.112B 0.00
Adicet Bio (ACET) United States $0.110B 0.00
Rapt Therapeutics (RAPT) United States $0.108B 0.00
BioAtla (BCAB) United States $0.107B 0.00
Immunic (IMUX) United States $0.106B 0.00
X4 Pharmaceuticals (XFOR) United States $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.104B 0.00
Alto Neuroscience (ANRO) United States $0.104B 0.00
Genelux (GNLX) United States $0.101B 0.00
Werewolf Therapeutics (HOWL) United States $0.098B 0.00
Cellectis S.A (CLLS) France $0.097B 0.00
HilleVax (HLVX) United States $0.097B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.096B 0.00
Coherus BioSciences (CHRS) United States $0.094B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.094B 0.00
Adlai Nortye (ANL) Cayman Islands $0.093B 0.00
Cidara Therapeutics (CDTX) United States $0.092B 0.00
Ovid Therapeutics (OVID) United States $0.092B 0.00
BioHarvest Sciences (CNVCF) Canada $0.092B 0.00
Renovaro (RENB) United States $0.091B 0.00
InflaRx (IFRX) Germany $0.089B 0.00
Leap Therapeutics (LPTX) United States $0.089B 0.00
Genenta Science S.p.A (GNTA) Italy $0.089B 0.00
I-Mab (IMAB) China $0.088B 0.00
Cue Biopharma (CUE) United States $0.087B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.086B 0.00
Agenus (AGEN) United States $0.085B 0.00
VistaGen Therapeutics (VTGN) United States $0.084B 0.00
Chimerix (CMRX) United States $0.084B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Oncolytics Biotech (ONCY) Canada $0.082B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
IO Biotech (IOBT) Denmark $0.081B 0.00
Aileron Therapeutics (ALRN) United States $0.081B 0.00
ALX Oncology Holdings (ALXO) United States $0.080B 0.00
Aerovate Therapeutics (AVTE) United States $0.079B 0.00
CytomX Therapeutics (CTMX) United States $0.078B 5.88
CervoMed (CRVO) United States $0.077B 0.00
MediciNova (MNOV) United States $0.077B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Bluebird Bio (BLUE) United States $0.074B 0.00
Boundless Bio (BOLD) United States $0.074B 0.00
TELA Bio (TELA) United States $0.074B 0.00
BeyondSpring (BYSI) United States $0.073B 0.00
DBV Technologies S.A (DBVT) France $0.071B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.20
ZIVO Bioscience (ZIVO) United States $0.071B 0.00
Syros Pharmaceuticals (SYRS) United States $0.069B 0.00
Celularity (CELU) United States $0.068B 0.00
Quince Therapeutics (QNCX) United States $0.067B 0.00
Precision BioSciences (DTIL) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.063B 0.00
Connect Biopharma Holdings (CNTB) United States $0.062B 0.00
Monopar Therapeutics (MNPR) United States $0.062B 0.00
Omega Therapeutics (OMGA) United States $0.062B 0.00
Theratechnologies (THTX) Canada $0.060B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.059B 0.00
Shattuck Labs (STTK) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
Affimed (AFMD) Germany $0.058B 0.00
OnKure Therapeutics (OKUR) United States $0.057B 0.00
Immuneering (IMRX) United States $0.057B 0.00
Vor Biopharma (VOR) $0.057B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Aadi Bioscience (AADI) United States $0.052B 0.00
Elicio Therapeutics (ELTX) United States $0.050B 0.00
Atara Biotherapeutics (ATRA) United States $0.050B 0.00
Imunon (IMNN) United States $0.049B 0.00
Immix Biopharma (IMMX) United States $0.048B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
HOOKIPA Pharma (HOOK) United States $0.044B 0.00
Intensity Therapeutics (INTS) United States $0.044B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.043B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
Rallybio (RLYB) United States $0.041B 0.00
VTv Therapeutics (VTVT) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.040B 0.00
Clene (CLNN) United States $0.040B 0.00
Passage Bio (PASG) United States $0.040B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.038B 0.00
CalciMedica (CALC) United States $0.038B 0.00
NextCure (NXTC) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.037B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
Dare Bioscience (DARE) United States $0.034B 0.00
Elevation Oncology (ELEV) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Dyadic (DYAI) United States $0.032B 0.00
Aligos Therapeutics (ALGS) United States $0.032B 0.00
KALA BIO (KALA) United States $0.032B 0.00
Longeveron (LGVN) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.030B 0.00
Ocean Biomedical (OCEA) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Estrella Immunopharma (ESLA) United States $0.029B 0.00
Athira Pharma (ATHA) United States $0.029B 0.00
Opus Genetics (IRD) United States $0.029B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.028B 0.00
BioXcel Therapeutics (BTAI) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Curis (CRIS) United States $0.026B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Beyond Air (XAIR) United States $0.024B 0.00
Spruce Biosciences (SPRB) United States $0.023B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
LakeShore Biopharma (LSB) China $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
Cognition Therapeutics (CGTX) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
UNITY Biotechnology (UBX) United States $0.020B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Cadrenal Therapeutics (CVKD) United States $0.017B 0.00
Cocrystal Pharma (COCP) United States $0.017B 0.00
Tenax Therapeutics (TENX) United States $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
HCW Biologics (HCWB) United States $0.016B 0.00
IN8bio (INAB) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Evaxion Biotech (EVAX) Denmark $0.015B 0.00
Apollomics (APLM) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
COSCIENS Biopharma (CSCI) Canada $0.013B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cingulate (CING) United States $0.010B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Biora Therapeutics (BIOR) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Galecto (GLTO) Denmark $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.009B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
Carmell (CTCX) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Portage Biotech (PRTG) $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Exicure (XCUR) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00